Polydex Pharmaceuticals Ltd (POLXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in U.S. thousands)
| 01-2023 | 01-2022 | 01-2021 | 01-2020 | 01-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -766 | -552 | 212 | 251 | 231 |
| Depreciation Amortization | 328 | 331 | 290 | 273 | 275 |
| Income taxes - deferred | N/A | 63 | N/A | N/A | -63 |
| Accounts receivable | -73 | 185 | 408 | -329 | 432 |
| Accounts payable and accrued liabilities | -149 | 105 | 247 | -28 | -27 |
| Other Working Capital | -412 | 74 | 763 | -329 | 265 |
| Other Operating Activity | 221 | -290 | -655 | 357 | -378 |
| Operating Cash Flow | $-850 | $-85 | $1,265 | $195 | $734 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -171 | -152 | -286 | -358 | -339 |
| Purchase Of Investment | 369 | -19 | -56 | -996 | -3 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 619 |
| Investing Cash Flow | $198 | $-171 | $-341 | $-1,355 | $276 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -127 | -24 | -70 | -68 | -66 |
| Other Financing Activity | -57 | -61 | -52 | -32 | -23 |
| Financing Cash Flow | $-184 | $-84 | $-122 | $-101 | $-88 |
| Exchange Rate Effect | 106 | 55 | 143 | 37 | 39 |
| Beginning Cash Position | 1,030 | 1,314 | 370 | 1,594 | 633 |
| End Cash Position | 300 | 1,030 | 1,314 | 370 | 1,594 |
| Net Cash Flow | $-731 | $-284 | $944 | $-1,224 | $961 |
| Free Cash Flow | |||||
| Operating Cash Flow | -850 | -85 | 1,265 | 195 | 734 |
| Capital Expenditure | -171 | -152 | -286 | -358 | -340 |
| Free Cash Flow | -1,021 | -236 | 979 | -164 | 394 |